The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
Craig Johnson, 25, was driving with partner Julie Douglas and their one-year-old daughter Maisie when the rock was hurled at them.
A terminally ill five-year-old boy led out the England team at Wembley with his "best friend" Jermain Defoe.
It comes as the country faces a major migrant crisis with more than 62,000 stranded including outside the port of Piraeus.